Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390

Diabetes Care. 2023 May 1;46(5):e121-e122. doi: 10.2337/dci23-0016.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus* / epidemiology
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Humans
  • Hypoglycemic Agents
  • Thyroid Neoplasms* / epidemiology

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents